Skip to content

Improving Adherence to Medication in Stroke Survivors

Improving Adherence to Medication in Stroke Survivors: a single centre randomised controlled pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN38274953
Enrollment
60
Registered
2010-01-18
Start date
2009-12-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke/transient ischaemic attack Circulatory System Transient cerebral ischaemic attacks and related syndromes

Interventions

Intervention group: Two brief sessions, two weeks apart with a trained RA, lasting approximately 30 - 45 minutes each. Session 1 will focus on helping each patient draw up a specific plan, so as to e

Sponsors

University of Stirling (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male and female patients who have suffered first-time stroke (ischaemic and haemorrhagic) or transient ischaemic attack (TIA) 2. Age range 18 + years (no upper age range) 3. Discharged from the Edinburgh Western General Hospital stroke units and clinics 4. Prescribed secondary antihypertensive medication on discharge 5. Exhibiting sub-optimal adherence on the Medication Adherence Report Scale (score of 24 or less) 6. Living at home 7. Responsible for own medication

Exclusion criteria

Exclusion criteria: 1. Age below 18 years 2. Marked cognitive impairment (Mini-Mental State Examination [MMSE] less than 23) 3. Significant dysphasia (Frenchay screen greater than 13/20) 4. Already using Dosette boxes (or similar) to improve their medication adherence 5. Participants who are not responsible for their own medication

Design outcomes

Primary

MeasureTime frame
Medication adherence recorded using MEMS (Medication Event Monitoring System, MEMS® Aardex Ltd, Switzerland) pill containers which electronically record openings. We shall use the following main outcomes, counting each opening as a presumptive dose: 1. Percentage of doses taken 2. Percentage of days on which the correct number of doses was taken 3. Percentage of doses taken on schedule

Secondary

MeasureTime frame
1. MARS self-reported adherence of all secondary preventative medication 2. Systolic and diastolic blood pressure Recorded at baseline and 3-month follow-up.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 1, 2026